Inhibition of polo-like kinase 4 (PLK4): a new therapeutic option for rhabdoid tumors and pediatric medulloblastoma

por Sredni, Simone Treiger, Bailey, Anders W., Suri, Amreena, Hashizume, Rintaro, He, Xingyao, Louis, Nundia, Gokirmak, Tufan, Piper, David R., Watterson, Daniel M., Tomita, Tadanori
Publicado 2017

A Simple Procedure for Creating Scalable Phenotypic Screening Assays in Human Neurons

por Sridharan, BanuPriya, Hubbs, Christopher, Llamosas, Nerea, Kilinc, Murat, Singhera, Fakhar U., Willems, Erik, Piper, David R., Scampavia, Louis, Rumbaugh, Gavin, Spicer, Timothy P.
Publicado 2019

Evaluation of Protein Kinase Inhibitors with PLK4 Cross-Over Potential in a Pre-Clinical Model of Cancer

por Suri, Amreena, Bailey, Anders W., Tavares, Maurício T., Gunosewoyo, Hendra, Dyer, Connor P., Grupenmacher, Alex T., Piper, David R., Horton, Robert A., Tomita, Tadanori, Kozikowski, Alan P., Roy, Saktimayee M., Sredni, Simone T.
Publicado 2019